Sponsor

Tourcoing Hospital

Clinical research sponsor

Published trials12
Recruiting shown1
Roles2
SourceClinicalTrials.gov

Clinical trials

12 shown
Platelets Target the Circulating HIV Reservoir: Implications for Immunological FailureNCT07745530 · lead sponsor · 2025-04-01
RECRUITING
Assessment of Sleep Disordersin People Living With HIV in the Era of New Antiretroviral Therapies in North of FranceNCT06441383 · lead sponsor · 2024-07-01
UNKNOWN
Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)NCT05074147 · lead sponsor · 2022-05-01
WITHDRAWN
HIV and Inflammatory or Autoimmune Disease: Rare Patients, Many Questions (MAIVIH)NCT05036811 · lead sponsor · 2021-06-07
UNKNOWN
Impact of Containment and the Current Epidemic on the Sexual Risk-taking of People Using PrEP to Prevent HIV Infection.NCT04772326 · lead sponsor · 2021-02-16
UNKNOWN
Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2)NCT04581746 · lead sponsor · 2020-11-25
UNKNOWN
Influenza Vaccination in Patients Living With HIV in the Northern RegionNCT04402684 · lead sponsor · 2020-04-10
COMPLETED
Study of the Prevalence and Associated Factors With Hypogonadism in HIV + MenNCT02665559 · lead sponsor · 2013-01-01
COMPLETED
Duration of Dual Antiretroviral Therapy in Virologically Suppressed People Living With HIV and Factors Associated With Switching to Tritherapy : a Real-life CohortNCT06107140 · lead sponsor · 2011-01-01
COMPLETED
Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot OsteomyelitisNCT02123628 · lead sponsor · 2007-06-01
COMPLETED
Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIVNCT03671291 · collaborator · 2019-04-03
COMPLETED
Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple TherapyNCT02302547 · collaborator · 2014-12-01
COMPLETED

Sponsor roles

lead sponsor10
collaborator2

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.